Description
Research overview
CJC-1295 is a modified growth hormone-releasing hormone analog. The No DAC designation is used in research catalogs to distinguish shorter-acting modified GRF-style materials from DAC-albumin-binding variants.
Research applications
- GHRH receptor signaling and growth hormone axis research models.
- Comparative studies involving GHRH analogs, secretagogues, and peptide modifications.
- Assay workflows focused on receptor activation, pathway timing, and peptide structure-function relationships.
Catalog benefits
- No DAC naming is shown clearly to reduce confusion with DAC-labeled CJC products.
- Professional research-use copy with no anti-aging, performance, or treatment language.
- Consistent handling notes for a lyophilized peptide research material.
Research-use notice: This product is not intended to diagnose, treat, cure, or prevent disease and is not for human or animal consumption.
Reviews
There are no reviews yet.